CDRI as an Instrument to Evaluate Infants With Developmental Problems Associated With Autism
DOI:
https://doi.org/10.1590/1982-43272560201511Abstract
This exploratory study investigates the contributions the Clinical Risk Indicators in Child Development (CDRI) may bring for the evaluation of infants who might be considered in autistic development. To do so, results of the evaluation – using CDRI and the Modified Checklist for Autism (M-CHAT) – of 43 babies who were 18 months old were compared. The present study showed that autism is amongst the risks the CDRI detects. The statistical analysis highlights that the axis Subject Assumption (SA) may not differentiate infants who present developmental problems associated with autism from typically developing ones. The Alternate Presence/Absence (PA) axis seems to be the one that most distinguishes these groups of infants. The clinical vignette demonstrates that CDRI can be used as a guide that helps to understand the family dynamics and can guide the interventions made in public health services.Downloads
Downloads
Published
Issue
Section
License
The Editorial Board authorizes free access to and distribution of published contentes, provided that the source is cited, that is, granding credit to the authors and Paidéia and preserving the full text. The author is allowed to place the final version (postprint / editor’s PDF) in an institutional/thematic repositor or personal page (site, blog), immediately after publication, provided that it is available for open access and comes without any embargo period. Full reference should be made to the first publication in Paidéia. Access to the paper should at least be aligned with the access the journal offers.
As a legal entity, the University of São Paulo at Ribeirão Preto School of Philosophy, Sciences and Languages owns and holds the copyright deriving from the publication. To use the papers, Paidéia adopts the Creative Commons Licence, CC BY-NC non-commercial attribution. This licence permits access, download, print, share, reuse and distribution of papers, provided that this is for non-commercial use and that the source is cited, giving due authorship credit to Paidéia. In these cases, neither authors nor editors need any permission.
When deriving from research involving human beings, manuscripts need IRB approval, in compliance with the guidelines and standards of the Brazilian National Health Council Resolution 196/96 – Ministry of Health. Authors should attach the digital copy of the IRB declaration of approval, according to instructions displayed further ahead.
